| Primary |
| Product Used For Unknown Indication |
100.0% |
|
| Dysphagia |
50.0% |
| Neurodegenerative Disorder |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.3% |
| Drug Use For Unknown Indication |
13.5% |
| Sciatica |
10.7% |
| Hypertension |
5.4% |
| Pain |
5.2% |
| Toothache |
5.2% |
| Neck Pain |
4.7% |
| Rheumatoid Arthritis |
3.0% |
| Back Pain |
2.4% |
| Herpes Zoster |
2.2% |
| Pneumonia |
2.2% |
| Diabetes Mellitus |
2.1% |
| Migraine |
2.1% |
| Bronchitis |
1.7% |
| Hypothyroidism |
1.7% |
| Neuralgia |
1.7% |
| Peripheral Arterial Occlusive Disease |
1.7% |
| Depression |
1.5% |
| Gastrointestinal Disorder |
1.5% |
| Hypercholesterolaemia |
1.3% |
|
| Cytolytic Hepatitis |
13.4% |
| Vomiting |
13.4% |
| Toxic Skin Eruption |
9.8% |
| Somnolence |
6.1% |
| Disorientation |
4.9% |
| Pruritus |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Gamma-glutamyltransferase Increased |
3.7% |
| Hallucination |
3.7% |
| Infection |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Neutropenia |
3.7% |
| Pemphigus |
3.7% |
| Renal Failure Acute |
3.7% |
| Suicide Attempt |
3.7% |
| Wrong Drug Administered |
3.7% |
| Confusional State |
2.4% |
| Dyspnoea |
2.4% |
| Erythema Multiforme |
2.4% |
| Fall |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.0% |
| Rheumatoid Arthritis |
15.8% |
| Drug Use For Unknown Indication |
11.0% |
| Hypertension |
8.7% |
| Pain |
7.9% |
| Ankylosing Spondylitis |
6.3% |
| Depression |
4.0% |
| Osteoporosis |
3.5% |
| Hypercholesterolaemia |
2.7% |
| Hepatitis C |
2.6% |
| Back Pain |
2.4% |
| Insomnia |
2.3% |
| Atrial Fibrillation |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Anxiety |
1.9% |
| Crohn's Disease |
1.7% |
| Neuralgia |
1.7% |
| Pain In Extremity |
1.5% |
| Prophylaxis |
1.4% |
| Hypothyroidism |
1.2% |
|
| Weight Decreased |
14.8% |
| Vomiting |
9.6% |
| Cerebellar Haemorrhage |
7.0% |
| Pulmonary Tuberculosis |
7.0% |
| Urinary Tract Infection |
7.0% |
| Shock Haemorrhagic |
5.2% |
| Tachycardia |
5.2% |
| Vertigo |
5.2% |
| Pulmonary Embolism |
4.3% |
| Renal Failure Acute |
4.3% |
| Infusion Related Reaction |
3.5% |
| Sepsis |
3.5% |
| Subdural Haematoma |
3.5% |
| Toxic Skin Eruption |
3.5% |
| Vision Blurred |
3.5% |
| Anaemia |
2.6% |
| Asthenia |
2.6% |
| Fall |
2.6% |
| Haematoma |
2.6% |
| Lipase Increased |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
37.5% |
| Neuralgia |
18.8% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Anxiety |
6.3% |
| Gastritis |
6.3% |
| Hypertension |
6.3% |
| Post Herpetic Neuralgia |
6.3% |
| Respiratory Failure |
6.3% |
|
| Orthostatic Hypotension |
40.0% |
| Psychomotor Retardation |
40.0% |
| Urinary Retention |
20.0% |
|
